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INTRODUCTION
Syringocystadenocarcinoma papilliferum (SCACP) is listed
in the WHO classification of skin tumor as the malignant
form of syringocystadenoma papilliferum (SCAP) (1). Most
lesions seem to have arisen from long-standing SCAP (2).
Histopathologically, SCACP has many structural similarities
with SCAP, but it can be differentiated from SCAP in that
it has an asymmetric and poorly circumscribed structure of
tumor, often extending deep into the subcutaneous fat, and
atypical cells, many of which are in mitosis (2).
To our knowledge, no case of SCACP have been reported in
the Korean medical literature. Herein we report a case of
SCACP occurring on the right supra-pubic area of a 65-yr-
old Korean male patient.
CASE REPORT
A 65-yr-old Korean man presented with a single nodule
on the right supra-pubic area. He had had the lesion for 2 yr.
The patient stated that the lesion began as a bean-sized pa-
pule and had increased gradually in size with time. It also
become painful and hemorrhagic. He had suffered from lim-
itation of motion of both legs because of osteomyelitis. His
personal medical history included hypertension with regu-
lar medication. Physical examination revealed a single, 3.4
×3.5 cm, erythematous, dome-shaped, and firm tumor sur-
rounded by bloody crust on the right supra-pubic area (Fig.
1). Regional lymph nodes were not palpable, and the physi-
cal examination did not reveal any remarkable findings except
for the mass.
Histopathologic examination revealed a tumor with a solid
and cystic pattern in the upper dermis (Fig. 2) and a tumor
of numerous irregular shaped structures in the deep dermis
(Fig. 3). Cystic invagination that connected to the skin sur-
face through infundibular structures was extending to the
dermis (Fig. 4A). The lower portion of cystic invagination
was composed of multiple layered epithelium with decapi-
tation on the luminal surface of the cells. There was a dense
infiltration of numerous plasma cells and lymphocytes in
the stroma of tumor (Fig. 4B). Variable degrees of nuclear
atypia with large and hyperchromatic nuclei and mitotic
figures were observed in these tumor cells (Fig. 5). Based on
these histopathological findings, the diagnosis of SCACP
was made. Immunohistochemically the tumor cells showed
positive reaction to gross cystic disease fluid protein (GCD-
FP)-15, but negative reaction to carcinoembryonic antigen
(CEA) or human milk fat globules (HMFG)-1. 
Laboratory tests including complete blood count and uri-
nalysis were within normal limits or negative. Liver function
tests and hepatitis B serologic tests revealed chronic hepati-
tis B. Tumor markers (CEA,  -fetoprotein, prostate specific
antigen, and CA19-9), chest radiography, hepatobiliary sonog-
raphy and gastrocolonoscopy did not show any internal ma-
lignancy or metastasis. A computed tomography (CT) of ab-
domen and pelvis could not be checked because of the pati-
ent’s lower leg deformity.
Wide excisional surgery was performed to remove the tu-
mor. There has not been any signs of recurrence or metastasis
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Syringocystadenocarcinoma Papilliferum: A Case Report
Syringocystadenocarcinoma papilliferum (SCACP) is a rare form of adenocarcino-
ma of the skin. This is the malignant counterpart of syringocystadenoma papilliferum
(SCAP) and usually develops on the scalp in a long-standing lesion identified clini-
cally as SCAP. We describe a 65-yr-old Korean man with a nodule on the right
supra-pubic area with a 2-yr duration. Histologically this tumor had a similar overall
configuration as in SCAP, but the tumor was asymmetric and poorly circumscribed,
extending into the deep dermis and showed cytologic atypia. The tumor cells show-
ed positive reaction to GCDFP-15, but negative reaction to CEA and HMFG-1. We
established the diagnosis of SCACP in the patient, and a wide excision was per-
formed to remove the tumor. The patient has been well without relapse or metas-
tasis for 2 yr. 
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for 2 yr after the opertaion.
DISCUSSION
SCACP is one of the sweat gland carcinomas and is regard-
ed as the malignant counterpart of SCAP (1). Although SCAP
is frequently encountered clinically, SCACP is rarely ob-
served and its clinical and histologic characteristics are not
well known. Only eight cases of SCACP have been reported
in the literature (3-8) (Table 1). The male (n=4)-to-female
(n=4) ratio was 1:1. The patients’ age ranged from 47 to 74
yr, having SCACP in their scalp. Clinically, the lesion shows
skin-colored or yellowish papules or nodules that remain
unchanged for many years but then begin to enlarge sud-
denly with bleeding or ulceration (2). Usually the lesion is
covered with crusts as a consequence of secretion of apocrine
epithelial cells (2). Its size varies from 2.5 to 13 cm. The
duration of disease progression from the lesion to SCACP
has been more than scores of years, but in cases of Arai et al.
Case No. 
(Refe-
rence 
No.)
Sex/
Age
(yr)
Sites Size (cm)
Duration
(yr)
Metasta-
sis
1 (3) F/74 Scalp 6.5×5.5×3.5 30 (-)
2 (3) F/71 Back 3 Many years (-)
3 (4) F/50 Scalp 6.5×6.5×2 Many years Regional
lymph
node (+)
4 (5) F/52 Chest 13×8×5 20 Regional
lymph 
node(+)
5 (6) M/47 Scalp 2.5 Many years (-)
6 (7) M/61 Perianal 6 10 (-)
7 (8) M/64 Scalp 3.5×2.5 2 (-)
8 (9) M/60 Auricle 4×4, 1×1 Many years (-)
9 (our  M/65 Supra-pubic 3.4×3.5 2 (-)
case)
Table 1. Cases of syringocystdenocarcinoma papilliferum in
the literature
Fig. 1. A single 3.4×3.5 cm-sized erythematous dome-shaped
nodule covered with bloody crust on the right suprapubic area.
Fig. 2. A low-power view of the lesion shows a tumor with a solid
and cystic pattern in the upper dermis and diffusely infiltrating the
lower dermis (H&E, ×1). 
Fig. 3. Tumor cells of strand or cord structures in the deep reticu-
lar dermis with desmoplastic stroma (H&E, ×40).764 S.H. Park, Y.M. Shin, D.H. Shin, et al.
(7) and our case rapid development for two years was observ-
ed. Only surgical excision was performed in all reported cases.
Histopathologically, as in SCAP, tumor shows deep epi-
dermal cystic invaginations containing numerous papillae.
Neoplastic cells lining the cystic cavities are connected to
the skin surface through funnel-shaped structures lined by
infundibular epithelium. The upper part of invaginations is
made up of keratinizing squamous epithelium, whereas the
lower part and papillae are composed of two- or multi-lay-
ered epithelium. Cells of the inner layer have columnar with
oval nuclei and abundant eosinophilic cytoplasm and decap-
itation on the luminal surface, while the cells of the outer
layer are small, cuboidal of flattened and have scanty cyto-
plasm and oval nuclei. Stroma of the tumor contains a dense
inflammatory infiltrate, composed of numerous plasma cells
and lymphoid cells (8). Occasionally, numerous normal apoc-
rine glands can be found. However, SCACP can be different
from SCAP in that it has an asymmetric structure of tumor
and the boundary is not clear; often tumor cells infiltrate the
deep dermis or subcutaneous fat in tubular, cystic or solid
types; neoplastic cells exhibit crowed nuclei, variable degrees
of nuclear atypia, and numerous mitotic figures (2, 8). From
Fig. 4. (A) Cystic in-
vagination connect-
ed to the infundibu-
lar portion extends
downward (H&E, ×
40). (B) Inferior por-
tion of cystic invagi-
nation lined by multi-
ple layered epitheli-
um with decapitation
on the luminal surfa-
ce of the cells, nume-
rous plasma cells and
lymphocytes in the
stroma (H&E, ×100). A B
Fig. 5. (A) Tumor cells having large and hyperchromatic nuclei (H&E, ×200). (B) Hyperchromatic nuclei and mitotic figures were observed
in these tumor cells (H&E, ×200).
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the above figdings, SCACP can be considered malignant.
Our case could be diagnosed as SCACP since it was shown
that tumor cells were infiltrating into the deep dermis and
atypical cells were observed along with the characteristics of
SCAP. 
Uncommonly, SCAP had a tubular dermal component or
tubular apocrine adenoma. However, in contrast with the
dermal component of SCACP, dermal tumor cells in our case
were arranged with varying sizes and shapes such as strand,
cord, or angular shapes. Also, dermal component was hori-
zontally oriented as was the case for most malignant neo-
plasms.
In three previous cases (3, 6, 7), since the basement mem-
brane of these papillations was intact and there was no invol-
vement of the dermis, the specimens were diagnosed as SC-
ACP in situ. 
Cuataneous metastases from breast or gastrointestinal can-
cers should be differentiated from SCACP (4). They lack
papillary structures containing deep invaginations as seen in
SCACP. Metastatic thyroid carcinoma and hidradenoma pa-
pilliferum should also be included in the differential diag-
nosis due to their papillary structures (8). 
Immunohistochemical and histochemical features of SCA-
CP have been reported in 3 cases (5-7). Positive reactions to
diastase-resistance periodic acid-Schiff (PAS) and cytokeratin
were observed in all 3 cases and immunoreactivities to CEA
showed positive reactions in 2 cases (5, 7). Ishida et al. (6)
reported negativity to GCDFP-15 and CEA, and loss of im-
munoreactivities to CEA and GCDFP-15 in SCACP might
be associated with its malignant de-differentiation in com-
parision with SCAP; however, Arai et al. (7) observed immu-
noreactivities to CEA and GCDFP-15 and stated that the
loss of immunoreactivities to CEA and GCDFP-15 were not
associated with the malignant de-differentiation. GCDFP-
15 may be positive in both apocrine and eccrine units (9).
HMFG-1 is positive in normal apocrine gland and tumors
with apocrine differentiation (10). Therefore, HMFG-1 is
thought to be a marker for apocrine differentiation in skin
neoplasms (10). Positivity for GCDFP-15 and negativity
for CEA and HMFG-1 were observed in our case.
The histogenesis of SCAP and SCACP is controversial.
However, the differentiaton of apocrine glands is recently
supported by following findings: decapitation is shown on
the luminal surface of inner layer cells; the tumor is connect-
ed to folliculosebaceous structures; and there is apocrine glands
in the underlying tissues (2, 7). In our case, decapitation and
cystic invagination from the infundibular structure support
the hypothesis that SCACP originates from apocrine glands.
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